Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

Abstract • About • The 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Cervical Cancer

  Free Subscription


17.11.2025

1 Abdom Radiol (NY)
1 ACS Appl Mater Interfaces
1 ACS Omega
1 Am J Trop Med Hyg
1 Ann Med
1 Arch Public Health
1 Biochem Genet
1 Biol Trace Elem Res
2 BMC Cancer
1 BMC Geriatr
1 BMC Public Health
1 BMC Womens Health
1 BMJ Open
1 Br J Cancer
1 Brachytherapy
1 Cancer Cell Int
1 Cancer Med
1 Cancer Sci
1 Cancers (Basel)
1 Crit Rev Immunol
1 Cytojournal
1 Diagnostics (Basel)
1 Drugs
1 Eur J Case Rep Intern Med
1 Explor Target Antitumor Ther
1 Free Radic Biol Med
2 Front Oncol
1 Front Vet Sci
1 Gynecol Oncol Rep
1 Healthcare (Basel)
1 HIV Med
1 Int J Biol Macromol
1 Int J Cancer
3 Int J Gynecol Cancer
2 Int J Mol Sci
1 Int J Surg
1 Integr Cancer Ther
1 J Appl Clin Med Phys
1 J Formos Med Assoc
1 J Gynecol Obstet Hum Reprod
1 J Natl Cancer Inst
1 J Pharm Biomed Anal
1 J Radiat Res
1 Mater Today Bio
1 PeerJ
2 PLoS One
1 Radiat Oncol
1 Reprod Biol
1 Rev Med Liege
1 SAGE Open Nurs
1 Sci Transl Med
1 Support Care Cancer
2 Taiwan J Obstet Gynecol
1 Value Health Reg Issues


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Abdom Radiol (NY)

  1. LIN W, Lan X, Huang W, Tang S, et al
    Preoperative prediction of cervical cancer recurrence using explainable MRI radiomics: a SHAP-Guided machine learning study.
    Abdom Radiol (NY). 2025 Nov 10. doi: 10.1007/s00261-025-05261.
    PubMed         Abstract available


    ACS Appl Mater Interfaces

  2. NUNZIATA G, Limiti E, Aramini D, Nava M, et al
    pH-Thermo Dual-Responsive Polymeric Nanoparticles for Women's Health: Dual Action Against Cervical and Ovarian Cancer Cells.
    ACS Appl Mater Interfaces. 2025;17:61888-61904.
    PubMed         Abstract available


    ACS Omega

  3. ARDILA-CHANTRE N, Barragan-Cardenas AC, Reyes-Calderon JE, Franco-Zambrano DS, et al
    A Lactoferricin B/Buforin Chimeric Peptide Causes a Rapid, Selective, Prolonged Cytotoxic Effect and Induces Apoptosis in HPV18-Positive Cervical Cancer Cells.
    ACS Omega. 2025;10:51143-51157.
    PubMed         Abstract available


    Am J Trop Med Hyg

  4. SENTHILKUMAR S, Chitale RA, Kempaiah P, Saraf D, et al
    Eliminating Cervical Cancer in India: Challenges and Prospects.
    Am J Trop Med Hyg. 2025 Nov 11:tpmd250396. doi: 10.4269/ajtmh.25-0396.
    PubMed         Abstract available


    Ann Med

  5. YIN M, Dai J, Sun R, Wang Y, et al
    Diagnostic performance of PAX1 methylation as a biomarker for cervical lesions: a clinical study and meta-analysis.
    Ann Med. 2025;57:2583319.
    PubMed         Abstract available


    Arch Public Health

  6. DE PAEPE E, Nanyonjo G, Vermandere H, Ssetaala A, et al
    Cervical cancer screening policies and implementation in Uganda - a qualitative study on policymakers', cervical cancer experts' and gynecologists' perspectives.
    Arch Public Health. 2025;83:270.
    PubMed         Abstract available


    Biochem Genet

  7. KAMATE B, Kassogue Y, Diakite B, Traore B, et al
    Distribution of High-Risk Human Papillomavirus in Self-Collected Cervicalvaginal Samples from the General Malian Population.
    Biochem Genet. 2025;63:5053-5066.
    PubMed         Abstract available


    Biol Trace Elem Res

  8. LIU JJ, Zou JH, Dong B, Lu XP, et al
    Inhibitory Effect of TrxR Inhibitor Ag (?) Schiff Base Complex Against Cervical Cancer Via ROS-mediated ASK1/MAPK Signaling and Autophagy.
    Biol Trace Elem Res. 2025 Nov 9. doi: 10.1007/s12011-025-04895.
    PubMed         Abstract available


    BMC Cancer

  9. VENGHATERI JB, Nathani P, Goyal S, Sarang B, et al
    Low participation in cancer screening in India: a scoping review of breast and cervical cancer programs.
    BMC Cancer. 2025;25:1724.
    PubMed         Abstract available

  10. DOFUTSU M, Aichi M, Itai T, Shinoda S, et al
    Peripheral lymphocyte count as a prognostic marker in cervical cancer patients treated with immune checkpoint inhibitors: a retrospective study.
    BMC Cancer. 2025;25:1762.
    PubMed        


    BMC Geriatr

  11. SAHIN G, Ulu FY, Yuksel IT
    Predictive determinants of CIN II + lesions in women over 65 years old: the contribution of HPV, colposcopy, and double immunostaining techniques.
    BMC Geriatr. 2025;25:855.
    PubMed         Abstract available


    BMC Public Health

  12. BASHARI N, Davari M, Akbarisari A, Khorasani E, et al
    Cost-effectiveness analysis of different types of human papillomavirus vaccination to prevent cervical cancer in Iran.
    BMC Public Health. 2025;25:3927.
    PubMed        


    BMC Womens Health

  13. NTHAMBI L, Temmerman M, Macharia WM, Nyagol J, et al
    Factors associated with cervical cancer screening among women attending maternal child health clinics in Kenya.
    BMC Womens Health. 2025;25:549.
    PubMed         Abstract available


    BMJ Open

  14. TATARCHUK T, Kalugina L, Antipkin Y, Tutchenko T, et al
    Exploring awareness, attitudes and clinical practices of Ukrainian health professionals regarding human papillomavirus and vaccination: a qualitative study.
    BMJ Open. 2025;15:e089968.
    PubMed         Abstract available


    Br J Cancer

  15. GORI S, Venturelli F, Carozzi F, Giorgi Rossi P, et al
    Correction: Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology.
    Br J Cancer. 2025 Nov 11. doi: 10.1038/s41416-025-03250.
    PubMed        


    Brachytherapy

  16. KIM G, Antaki M, Schmidt EJ, Roumeliotis M, et al
    Automatic digitization of applicator and catheters for MRI-guided cervical cancer brachytherapy.
    Brachytherapy. 2025 Nov 6:S1538-4721(25)00318.
    PubMed         Abstract available


    Cancer Cell Int

  17. OUYANG S, Xiong K, Chen P, Liu X, et al
    Mechanism of interaction between ANXA6 and cGAS to regulate STING signaling pathway and promote ferroptosis in cervical cancer.
    Cancer Cell Int. 2025;25:397.
    PubMed         Abstract available


    Cancer Med

  18. GAN J, Cao D, Zhou H, Yu M, et al
    Cervical Adenocarcinoma: What's Special About the Long-Term Reproductive and Oncological Outcomes of Fertility-Sparing Radical Trachelectomy in It?
    Cancer Med. 2025;14:e71366.
    PubMed         Abstract available


    Cancer Sci

  19. IKAWA T, Nakata K, Morishima T, Yoshida KI, et al
    Secondary Lower-Body Sarcomas in Cervical Cancer Survivors Following Surgery, Radiotherapy, or Both: A Population-Based Study.
    Cancer Sci. 2025 Nov 9. doi: 10.1111/cas.70229.
    PubMed         Abstract available


    Cancers (Basel)

  20. GOROSTIDI M, Angeles M, Gil-Ibanez B, Lekuona A, et al
    Surgical Staging in Locally Advanced Cervical Cancer: Precision, Risks, and the 'Helmet' Analogy.
    Cancers (Basel). 2025;17:3487.
    PubMed         Abstract available


    Crit Rev Immunol

  21. XIAN Z, Pang X
    STROBE-Cross-Population Mendelian Randomization Analysis of Circulating Inflammatory Proteins and Cervical Cancer Risk in European and Asian Populations.
    Crit Rev Immunol. 2025;45:43-51.
    PubMed         Abstract available


    Cytojournal

  22. ZOUZOULAS D, Chatzistamatiou K, Tsolakidis D
    The role of p16/Ki-67 dual staining in cervical cancer screening and cervical precancerous lesions follow-up.
    Cytojournal. 2025;22:78.
    PubMed        


    Diagnostics (Basel)

  23. OZKAYA UCAR Y, Aytekin O, Yalcin N, Oktar O, et al
    Survival Outcomes and Prognostic Factors for Patients in Early Stage Cervical Cancer: A Multicentric Study in Turkey.
    Diagnostics (Basel). 2025;15:2757.
    PubMed         Abstract available


    Drugs

  24. KEAM SJ
    Famitinib: First Approval.
    Drugs. 2025;85:1613-1620.
    PubMed         Abstract available


    Eur J Case Rep Intern Med

  25. DEWAN P, Somani V, Mon MM
    When Metastatic Cervical Cancer Presents as Miliary Lung Nodules.
    Eur J Case Rep Intern Med. 2025;12:005806.
    PubMed         Abstract available


    Explor Target Antitumor Ther

  26. PAROLA S, Colombo I
    Bispecific antibodies in the treatment of epithelial ovarian, endometrial, and cervical cancer: an overview of current applications, challenges, and emerging opportunities.
    Explor Target Antitumor Ther. 2025;6:1002345.
    PubMed         Abstract available


    Free Radic Biol Med

  27. DANG T, You Y, Wei L, Li Q, et al
    Corrigendum to "ICAT drives lactylation of tumor-associated macrophages via the c-Myc-ENO1 axis to promote cervical cancer progression" [Free Radic. Biol. Med. 241 (2025) 316-329].
    Free Radic Biol Med. 2025 Nov 11:S0891-5849(25)01337.
    PubMed        


    Front Oncol

  28. KANDASAMY G, Orayj K, Shorog E, Alshahrani AM, et al
    Knowledge and attitudes toward human papillomavirus and cervical cancer prevention among women in the Asir Region, Saudi Arabia: a cross-sectional study.
    Front Oncol. 2025;15:1608568.
    PubMed         Abstract available

  29. KANDASAMY G, Orayj K, Shorog E, Alshahrani AM, et al
    Correction: Knowledge and attitudes toward human papillomavirus and cervical cancer prevention among women in the Asir Region, Saudi Arabia: a cross-sectional study.
    Front Oncol. 2025;15:1726725.
    PubMed         Abstract available


    Front Vet Sci

  30. WANG CR, Wang DM, Yin GY, Wang YH, et al
    Isolation and characterization of canine adenovirus type 2 (CAV-HN45) and its selective infection of human cervical cancer cells with preliminary oncolytic potential.
    Front Vet Sci. 2025;12:1692395.
    PubMed         Abstract available


    Gynecol Oncol Rep

  31. KERNELL C, MacDuffie E, Lin X, Gao L, et al
    HPV profiles in Botswana: An analysis of healthy women, cervical intraepithelial neoplasia, and invasive cervical cancer.
    Gynecol Oncol Rep. 2025;62:101971.
    PubMed         Abstract available


    Healthcare (Basel)

  32. CHEN X, Yang Y, Li Y, Zhou J, et al
    Study on the Trend of Cervical Cancer Inpatient Costs and Its Influencing Factors in Economically Underdeveloped Areas of China, 2019-2023: An Analysis in Gansu Province.
    Healthcare (Basel). 2025;13:2663.
    PubMed         Abstract available


    HIV Med

  33. WALDECKER M, Taghavi K, Pasin C, Tarr PE, et al
    Factors associated with uptake of gynaecological care and cervical cancer screening among women in the Swiss HIV Cohort Study.
    HIV Med. 2025 Nov 11. doi: 10.1111/hiv.70137.
    PubMed         Abstract available


    Int J Biol Macromol

  34. LIN G, Guo X, Fu Z, Liu Z, et al
    Self-amplifying mRNA nanovaccine encoding GM-CSF-fused HPV16 E7 enhances immunogenicity and therapeutic efficacy against cervical cancer.
    Int J Biol Macromol. 2025 Nov 10:148933. doi: 10.1016/j.ijbiomac.2025.148933.
    PubMed         Abstract available


    Int J Cancer

  35. ORTEGA LLOBET M, Gray P, Baussano I, Elfstrom KM, et al
    Controlled trial of cervical cancer screening frequency among human-papillomavirus-vaccinated women.
    Int J Cancer. 2025 Nov 7. doi: 10.1002/ijc.70229.
    PubMed         Abstract available


    Int J Gynecol Cancer

  36. MATSUO K, Matsuzaki S, Roman LD
    Definition of intermediate risk cervical cancer and histology-specific survival interaction.
    Int J Gynecol Cancer. 2025 Oct 17:102749. doi: 10.1016/j.ijgc.2025.102749.
    PubMed        

  37. MASCILINI F, Mburu A, Ciancia M, Moro F, et al
    Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study.
    Int J Gynecol Cancer. 2025;35:102752.
    PubMed         Abstract available

  38. MANNING-GEIST BL, Miller M, Dagher C, Kim SH, et al
    Evaluation of toxicity after radical hysterectomy or trachelectomy and post-operative pelvic intensity-modulated radiation therapy with concurrent chemotherapy for cervical cancer.
    Int J Gynecol Cancer. 2025;35:102712.
    PubMed         Abstract available


    Int J Mol Sci

  39. PINEDA-MIGRANAS JA, Bravata-Alcantara JC, Cortes-Ortiz IA, Cortes-Malagon EM, et al
    Liquid Biopsy Biomarkers for Cervical Cancer: A Systematic Review.
    Int J Mol Sci. 2025;26:10503.
    PubMed         Abstract available

  40. SALMERON-BARCENAS EG, Martinez-Zayas A, Vargas-Mejia M, Villegas-Sepulveda N, et al
    DNMT Enzymes and Their Impact on Cervical Cancer: A State-of-the-Art Review.
    Int J Mol Sci. 2025;26:10496.
    PubMed         Abstract available


    Int J Surg

  41. HUANG H, Li X, Xu Q, Wu J, et al
    Impact of regional lymph node surgery and lymph node status on survival of small cell cervical cancer patients undergoing primary site surgery.
    Int J Surg. 2025 Nov 10. doi: 10.1097/JS9.0000000000003870.
    PubMed         Abstract available


    Integr Cancer Ther

  42. LINXI J, Shiling L, Hongli Z
    Comment on "Metabolic Effects of Healing Touch During Cervical Cancer Treatment: An Exploratory Analysis".
    Integr Cancer Ther. 2025;24:15347354251397374.
    PubMed        


    J Appl Clin Med Phys

  43. HUANG W, Liu T, Shen Y, Xiang Z, et al
    Automatic radiotherapy planning for deliverable plans using deep learning dose prediction and dose rings optimization in cervical cancer.
    J Appl Clin Med Phys. 2025;26:e70353.
    PubMed         Abstract available


    J Formos Med Assoc

  44. TSAI YL, Tam KW
    Reply to letter to Editor concerning "Impact of COVID-19 on cervical cancer screening: A cohort study".
    J Formos Med Assoc. 2025 Nov 6:S0929-6646(25)00590.
    PubMed        


    J Gynecol Obstet Hum Reprod

  45. FERREIRA P, Hagege M, Tran PL
    From policy to practice in cervical cancer prevention in Reunion Island.
    J Gynecol Obstet Hum Reprod. 2025 Nov 6:103067. doi: 10.1016/j.jogoh.2025.103067
    PubMed        


    J Natl Cancer Inst

  46. LIU Q, Wiese D, Pinheiro PS, Bispo JB, et al
    Association between racialized economic segregation and stage at diagnosis for 3 screenable cancers in New York City.
    J Natl Cancer Inst. 2025;117:2259-2271.
    PubMed         Abstract available


    J Pharm Biomed Anal

  47. JIANG Q, Xu R, Cheng J, Shi Y, et al
    Mechanisms underlying the therapeutic effects of Amygdalin in treating Cervical Cancer based on multi-omics analysis.
    J Pharm Biomed Anal. 2025;268:117232.
    PubMed         Abstract available


    J Radiat Res

  48. IKAWA T, Morishima T, Nakata K, Kishimoto K, et al
    Trends in radiotherapy use and implementation challenges among patients with cervical cancer: a multicenter study in Osaka, Japan.
    J Radiat Res. 2025 Nov 10:rraf066. doi: 10.1093.
    PubMed         Abstract available


    Mater Today Bio

  49. ZHANG Y, Lu Y, Li S, Zheng F, et al
    Precision theranostics in cervical Cancer: Harnessing stimuli-responsive hydrogels for tumor microenvironment-targeted therapy and diagnosis.
    Mater Today Bio. 2025;35:102392.
    PubMed         Abstract available


    PeerJ

  50. HUANG Y, Wei X, Guo Y, Su T, et al
    Incidence, persistence, and clearance of cervical human papillomavirus infection among gynecological outpatients in Kunming, Yunnan, China, 2019-2023: a retrospective cohort study.
    PeerJ. 2025;13:e20215.
    PubMed         Abstract available


    PLoS One

  51. CHEN J, Hong J, Chen K, Zhang X, et al
    Dosimetric divergence in ICBT vs. IC/ISBT configurations: Comparative analysis of three optimization algorithms for cervical cancer brachytherapy.
    PLoS One. 2025;20:e0335405.
    PubMed         Abstract available

  52. ORENGO JC, Bierrenbach AL, Aranda Flores CE, Lopez ED, et al
    Trends in the burden of HPV-associated cancers in Mexico: An analysis from 2011 to 2019.
    PLoS One. 2025;20:e0335307.
    PubMed         Abstract available


    Radiat Oncol

  53. SITTIWONG W, Prasartseree T, Tuntapakul P, Thaweerat W, et al
    Re-irradiation in oligorecurrence and oligometastatic cervical cancer in modern radiotherapy era.
    Radiat Oncol. 2025;20:168.
    PubMed         Abstract available


    Reprod Biol

  54. LI T, Xiong X, Xie T, Liu W, et al
    USP13 exacerbates the malignant progression of cervical cancer by inhibiting ECT2 ubiquitination and degradation.
    Reprod Biol. 2025;26:101095.
    PubMed         Abstract available


    Rev Med Liege

  55. ONGARO S, Desreux J, Tremblay-Lemoine PL, Schoenen S, et al
    [Cervical cancer screening : implementation of the hr-HPV test].
    Rev Med Liege. 2025;80:729-734.
    PubMed         Abstract available


    SAGE Open Nurs

  56. MTUYA CC, Cadstedt J, Mattsson J, Manhica HA, et al
    "Cervical Cancer-A Silent Disease in the Community"-A Qualitative Study on Awareness of Cervical Cancer in Tanzania.
    SAGE Open Nurs. 2025;11:23779608251393079.
    PubMed         Abstract available


    Sci Transl Med

  57. NAKAHASHI-OUCHIDA R, Mori H, Yuki Y, Machita T, et al
    Cationic nanogel-based nasal therapeutic HPV vaccine prevents the development of cervical cancer.
    Sci Transl Med. 2025;17:eado8840.
    PubMed         Abstract available


    Support Care Cancer

  58. CHEN X, Xia S, Han X, Han J, et al
    Reproductive concerns in young women with cervical cancer: latent profiles and key influencing factors.
    Support Care Cancer. 2025;33:1041.
    PubMed         Abstract available


    Taiwan J Obstet Gynecol

  59. CLAIRE LIN CC, Tai CC, Hung P, Tung YC, et al
    Community mobile health clinics' availability is associated with cervical cancer screening in rural and urban areas: A national cohort study in Taiwan.
    Taiwan J Obstet Gynecol. 2025;64:1024-1029.
    PubMed         Abstract available

  60. BUDIANA IN, Prayudi PKA, Mahendra INB, Remitha NPSI, et al
    Plasma level of cancer stem cell marker aldehyde dehydrogenase 1 (ALDH1) is higher in locally advance cervical cancer.
    Taiwan J Obstet Gynecol. 2025;64:1050-1055.
    PubMed         Abstract available


    Value Health Reg Issues

  61. HIDAYATI NR, Endarti D, Setiawan D
    Cost-Utility Analysis of Expanding Human Papillomavirus Vaccination to Adult Women in Indonesia: A Markov Model Approach.
    Value Health Reg Issues. 2025;50:101147.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.